Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20211110053031N1Phase 2Completed
Phase 2, randomised, single-blind trial in hypersalivation comparing Atropine arm, Ipratropium bromide arm and Amitriptyline arm (3 arms). Primary endpoint: Reduction of clozapine-induced sialorrhea. Started Jul 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20211110053031N1.